New Market Research Report on Global Agrochemical Industry and Emerging Markets

2012-11-22
Published : Nov-2012

This report provides agrochemical industry executives with strategically significant competitor information, analysis and insight, critical to the development and implementation of effective marketing and programs. The companies analyzed in this report include BASF, Bayer, Dow, DuPont, FMC, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta.

Objectives To establish comprehensive, factual and cost-effective information base on performance, capabilities, goals and strategies of the worlds leading agrochemical companies.

  • To help current suppliers realistically assess their technological and marketing capabilities vis-a-vis leading competitors. To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
  • To complement internal competitor information gathering efforts with strategic analysis, data interpretation and insight.
  • To identify least competitive market niches with significant growth potential. Rationale In a highly dynamic and fragmented agrochemical market, besieged by intense competition, the ability to anticipate new product introductions and marketing strategies is particularly important and can spell the difference between success and failure.

Methodology

The Top 10 report is based on a combination of primary and secondary information sources, including Venture Planning Groups proprietary database, developed during the firms continuous monitoring of the agrochemical industry, as well as over 100 syndicated studies and numerous proprietary single-client assignments.

This database contains information on major agrochemical companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the Top 10 companies product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Buy a copy of this report @ http://www.reportsnreports.com/reports/206092-innovative-agrochemical-technologies-and-emerging-markets.html

Published: November 2012
No. of Pages: 400

Price: Single User: US $ 1500                             Corporate User: US $ 3300

TABLE OF CONTENTS

WORLDWIDE MARKET OVERVIEW

COMPANY STRATEGIC ASSESSMENTS
BASF
Bayer
Dow
DuPont
FMC
Makhteshim-Agan
Monsanto
Nufarm
Sumitomo
Syngenta

SECTION I: EXECUTIVE SUMMARY
A 3-5 page synopsis of key sections.

SECTION II: BUSINESS ORGANIZATION
History of the company’s agrochemical business evolution,
which is imporant to understanding the corporate culture, management mentality and strategies.
Recent acquisitions, divestitures and major organizational changes.
Current organizational structure.

SECTION III: SENIOR MANAGEMENT
Names, titles and background of key executives.

SECTION IV: FACILITIES AND EMPLOYEES
Administrative, manufacturing and R&D
facilities in the U.S. and abroad.
Manufacturing practices.
New plants under construction.
The U.S. and international work force size and distribution.

SECTION V:TECHNOLOGICAL KNOW-HOW
Internally developed and acquired agrochemical and related
capabilities.
Proprietary technologies and patent litigation.

SECTION VI: PRODUCT PORTFOLIO
Review of major product lines.
Applications, advantages and weaknesses of leading products.

SECTION VII: MARKETING TACTICS
Promotional tactics.
Distribution approaches.
Product service and support.
Customer relations.

SECTION VIII: FINANCIAL ANALYSIS
Estimated sales by division, product line and
geographic region.
Five-year sales and operating profit
performance.

SECTION IX: R&D EXPENDITURES AND MAJOR PROGRAMS
Estimated R&D budget.
Research facilities and staff.
New technologies, products and applications in development.

SECTION X: COLLABORATIVE ARRANGEMENTS
Joint ventures, distribution, O.E.M. and licensing partners, both industrial and academic.
Terms of collaborative agreements and specific products involved.

SECTION XI: STRATEGIC DIRECTION
Specific business, new product development and marketing strategies.
Anticipated acquisitions, joint ventures and divestitures.

COMPARATIVE ANALYSIS
In this section of the report, the Top 10 companies will be ranked according to the following criteria:
Sales estimates in North America, Europe, Japan and other regions.
Sales by product category.
Operating profit and margins.
R&D expenditures, and others.

LIST OF TABLES

TABLE BF-1: BASF SALES AND PROFIT GROWTH
TABLE BF-2: BASF SALES BY BUSINESS SEGMENT
TABLE BF-3: BASF PROFIT BY BUSINESS SEGMENT
TABLE BF-4: BASF SALES BY GEOGRAPHIC REGION
TABLE BR-1: BAYER SALES BY SECTOR
TABLE BR-2: BAYER SALES BY GEOGRAPHIC REGION
TABLE BR-3: BAYER CROPSCIENCE SALES AND OPERATING PROFIT GROWTH
TABLE BR-4: BAYER CROPSCIENCE SALES BY PRODUCT LINE
TABLE DC-1: DOW SALES AND OPERATING PROFIT GROWTH
TABLE DC-2: DOW SALES BY OPERATING SEGMENT
TABLE DC-3: DOW SALES GROWTH BY OPERATING SEGMENT
TABLE DC-4: DOW SALES BY GEOGRAPHIC REGION
TABLE DC-5: DOW SALES GROWTH BY GEOGRAPHIC REGION
TABLE DC-6: DOW AGRICULTURAL SCIENCES SALES BY PRODUCT
TABLE DP-1: DUPONT SALES AND OPERATING PROFIT GROWTH
TABLE DP-2: DUPONT SALES BY INDUSTRY SEGMENT
TABLE DP-3: DUPONT SALES BY GEOGRAPHIC REGION
TABLE DP-4: DUPONT SALES GROWTH BY GEOGRAPHIC REGION
TABLE FM-1: FMC SALES AND PROFIT GROWTH
TABLE FM-2: FMC SALES BY BUSINESS SEGMENT
TABLE FM-3: FMC PROFIT BY BUSINESS SEGMENT
TABLE FM-4: FMC SALES BY GEOGRAPHIC REGION
TABLE MA-1: MAKHTESHIM-AGAN SALES AND OPERATING PROFIT GROWTH
TABLE MA-2: MAKHTESHIM-AGAN SALES BY PRODUCT LINE
TABLE MA-3: MAKHTESHIM-AGAN SALES GROWTH BY PRODUCT LINE
TABLE MA-4: MAKHTESHIM-AGAN SALES BY GEOGRAPHIC REGION
TABLE MA-5: MAKHTESHIM-AGAN SALES GROWTH BY GEOGRAPHIC REGION
TABLE MO-1: MONSANTO SALES AND OPERATING PROFIT GROWTH
TABLE MO-2: MONSANTO SALES BY GEOGRAPHIC REGION
TABLE MO-3: MONSANTO SALES GROWTH BY GEOGRAPHIC REGION
TABLE MO-4: MONSANTO SALES BY PRODUCT LINE
TABLE MO-5: MONSANTO SALES GROWTH BY PRODUCT LINE
TABLE NU-1: NUFARM SALES AND OPERATING PROFIT GROWTH
TABLE NU-2: NUFARM SALES BY BUSINESS SEGMENT
TABLE NU-3: NUFARM SALES GROWTH BY BUSINESS SEGMENT
TABLE NU-4: NUFARM SALES BY GEOGRAPHIC REGION
TABLE NU-5: NUFARM SALES GROWTH BY GEOGRAPHIC REGION
TABLE NU-6: NUFARM CROP PROTECTION SALES BY PRODUCT CATEGORY
TABLE SU-1: SUMITOMO SALES AND OPERATING PROFIT GROWTH
TABLE SU-2: SUMITOMO SALES BY BUSINESS SEGMENT
TABLE SU-3: SUMITOMO SALES GROWTH BY BUSINESS SEGMENT
TABLE SU-4: SUMITOMO SALES BY GEOGRAPHIC REGION
TABLE SU-5: SUMITOMO SALES GROWTH BY GEOGRAPHIC REGION
TABLE SU-6: SUMITOMO AGRICULTURAL CHEMICALS
SALES AND OPERATING PROFIT GROWTH
TABLE SY-1: SYNGENTA SALES AND OPERATING PROFIT GROWTH
TABLE SY-2: SYNGENTA SALES GROWTH BY PRODUCT LINE
TABLE SY-3: SYNGENTA OPERATING PROFIT GROWTH BY PRODUCT LINE
TABLE SY-4: SYNGENTA SALES GROWTH BY GEOGRAPHIC REGION

Filed in: Biotechnology
More Reports
Title Price Buy Now

Stem Cell Assays Market by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User – Global Forecast to 2027

“The stem cell assays market growth can be attributed to factors such as the rising demand for technologically advanced stem cell analysis instruments, increase in the prevalence of cancer & other diseases and rising number of biopharma and & biotechnology companies working on stem cell based therapies.” The stem cell assays market is projected to reach USD 4.5 Billion by 2027 from USD 1.9 Billion in 2022, at a CAGR of 17.7% during the forecast period. The growth of the market is projected to be driven by collaborations and agreements among market players for stem cell assay products & services, launch of new stem cell analysis systems such as flow cytometers and increase in R&D expenditure by biopharmaceutical and biotechnology companies. The viability/cytotoxici......
$

Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027

The nucleic acid isolation and purification market is expected to grow at a CAGR of 7.9% in the forecast period. The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. The emerging economies, improving regulatory and reimbursement scenario, and the growing adoption of molecular diagnostics and personalized medicines are expected to offer a wide range of growth opportunities for players in the market. However, the high cost of automated instruments is expected to hinder the growth of the market. As the world be......
$4950

Wound Care Biologics Market by Product (Biological Skin Substitutes, Topical Agents), Wound Type (Ulcers [Diabetic Foot, Venous, Pressure Ulcers], Surgical & Traumatic Wounds, Burns), End User (Hospitals, ASCs, Burn Centers) – Global Forecast to 2027

“Rising number of road accidents and associated traumatic wounds and growing incidence of burn injuries are driving the overall growth of the wound care biologics market” The global wound care biologics market is valued at an estimated USD 1.8 billion in 2022 and is projected to reach USD 2.4 billion by 2027, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as the growing incidence of burn injuries and the rising number of road accidents and associated traumatic wounds. However, the high cost of wound care biologic products and the risk associated with skin substitute failure are the major factors hampering the growth of this market. “The biological skin substitutes segment accounted for the highest growth rate in the wound care biologics ma......
$4950

Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) – Global Forecast to 2027

“The global bioanalytical testing services market is projected to grow at a CAGR of 15.6%” Bioanalytical testing involves analytical methods used for the detailed examination of biological and biotechnology products. Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules. The global bioanalytical testing services market is projected to reach USD 6.0 billion by 2027 from an estimated USD 2.9 billion in 2022, at a CAGR of 15.6% during the forecast period. “The Cell-based assays segment is expected to account for the largest share of the bioanalytical testing services market” The increasing prevalence of chronic diseases and the rising number of clinical trials ar......
$4950

Cell Analysis Market by Product & Service (Reagents & Consumables, Instruments), Technique (Flow Cytometry, High Content Screening), Process (Single-cell Analysis), End User (Pharmaceutical and Biotechnology Companies) – Global Forecast to 2027

“Single-cell analysis segment has gained significant traction in the recent years attributed to the widening applications of this technology in cancer research. This is further supplemented by the robust government initiatives targeted towards single-cell analysis research. The growth of the single-cell analysis segment is expected to drive the overall growth of the cell analysis market.” The global cell analysis market is projected to reach USD 28.6 Billion by 2027 from USD 17.7 Billion in 2022, at a CAGR of 10.1% during the forecast period. Key opportunities for the cell analysis market include, emerging economies, high risk of communicable diseases and pandemic outbreak, and increasing adoption of novel cellular assays in various cancer research applications. On the other hand, h......
$4950

3D Cell Culture Market by Type (Hydrogel, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharma, Biotech, Research, Cosmetics), Region – Global Forecast to 2027

“Increasing focus on developing alternative methods to animal testing, growing focus on personalized medicine is driving the overall growth of the3D Cell culture market” The global 3D cell culture market is valued at an estimated USD 1.3 billion in 2022 and is projected to reach USD 2.6 billion by 2027, at a CAGR of 15.6% during the forecast period. The growth of this market is mainly driven by factors such as the increasing focus on developing alternative methods to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, a lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to restrain the growth of this market during the f......
$4950

Tangential Flow Filtration Market by Product (System, Membrane Filter), Material (PES, PVDF, PTFE), Technique (Ultrafiltration), Application (Final Product Processing, Raw Material Filtration), End User (Pharma, Biotech), Region – Global Forecast to 2027

“Growth in the tangential flow filtration market can be attributed to factors such as the growing advantages of tangential flow filtration over normal flow filtration, rising R&D spending in pharmaceutical & biotechnology industries and increasing adoption of single-use technologies.” The global tangential flow filtration market is projected to USD 2.8 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 13.2% during the forecast period. The rising advantages of tangential flow filtration over normal flow filtration, increasing adoption of single-use technologies, and growing R&D spending in pharma-biotech companies. On the contrary, the high capital investments for setting up new production facilities are expected to restrain the market growth. “In 2021 the s......
$4950

Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs), Application (Therapeutic, Diagnostic), Disease (Infectious, Metabolic/Endocrine), Research Technology (Genomics, Proteomics, Metabolomics) – Global Forecast to 2029

“Increased focus on human microbiome therapy development to drive the growth of this market.” The human microbiome market is projected to reach USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development & development of human microbiome-based tests for early disease detection and diagnosis are also factors expected to support market growth. However, a lack of expertise and inadequate research on the human microbiome are factors expected to restrain this market's growth. “By product segment, the drugs segment accounted for the largest share of huma......
$4950

Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User – Global Forecast to 2026

“Increasing interest in exosome-based proceduresto Drive the Growth of Market” The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. “By product & service, the kits & reagents segment accounted for the largest share of the exosome research market” Based on product and service, the exosomes market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is further divided into antibodies, isolation, purification, quantitation kits & reagents, and other ki......
$4950

Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic) – Global Forecast to 2027

“Continuous technological innovations in NGS platforms is the key factors driving growth in the metagenomic sequencing market’’ The metagenomic sequencing market is expected to reach USD 4.3 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 18.4% during the forecast period. Growth in the metagenomic sequencing market is mainly driven by continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing, and the significant applications of metagenomics in various fields. “By technology segment, the shotgun metagenomic sequencing segment accounted for the fastest-growing segment of the metagenomic sequencing market” Based on technol......
$4950
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy